Stay updated with breaking news from Syn One Test. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CND Life Sciences is studying its Syn-One Test in hopes of predicting the conversion of RBD to a more advanced synucleinopathy.
/PRNewswire/ -- CND Life Sciences, an innovative medical diagnostics company pioneering the detection, visualization, and quantification of protein deposition...
/PRNewswire/ -- CND Life Sciences, an innovative medical diagnostics company pioneering the detection, visualization, and quantification of protein deposition...
/PRNewswire/ -- CND Life Sciences, Inc. (www.cndlifesciences.com), an innovative medical diagnostics company pioneering the detection, visualization, and...
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!